DSM-Firmenich Stock

DSM-Firmenich Equity 2024

DSM-Firmenich Equity

22.91 B EUR

Ticker

DSFIR.AS

ISIN

CH1216478797

WKN

A3D2TK

In 2024, DSM-Firmenich's equity was 22.91 B EUR, a 113.24% increase from the 10.74 B EUR equity in the previous year.

DSM-Firmenich Aktienanalyse

What does DSM-Firmenich do?

DSM-Firmenich ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing DSM-Firmenich's Equity

DSM-Firmenich's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding DSM-Firmenich's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating DSM-Firmenich's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

DSM-Firmenich's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in DSM-Firmenich’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about DSM-Firmenich stock

What is the equity of DSM-Firmenich this year?

DSM-Firmenich has equity of 22.91 B EUR this year.

What was the equity of DSM-Firmenich compared to the previous year?

The equity of DSM-Firmenich has increased/decreased by 113.24% increased compared to the previous year.

What impact does a high equity have on investors of DSM-Firmenich?

A high equity is advantageous for investors of DSM-Firmenich as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of DSM-Firmenich?

A low equity can be a risk for investors of DSM-Firmenich, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of DSM-Firmenich affect the company?

An increase in equity of DSM-Firmenich can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of DSM-Firmenich affect the company?

A reduction in equity of DSM-Firmenich can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of DSM-Firmenich?

Some factors that can affect the equity of DSM-Firmenich include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of DSM-Firmenich so important for investors?

The equity of DSM-Firmenich is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can DSM-Firmenich take to change the equity?

To change equity, DSM-Firmenich can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does DSM-Firmenich pay?

Over the past 12 months, DSM-Firmenich paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 1.37 %. For the coming 12 months, DSM-Firmenich is expected to pay a dividend of 1.6 EUR.

What is the dividend yield of DSM-Firmenich?

The current dividend yield of DSM-Firmenich is 1.37 %.

When does DSM-Firmenich pay dividends?

DSM-Firmenich pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DSM-Firmenich?

DSM-Firmenich paid dividends every year for the past 0 years.

What is the dividend of DSM-Firmenich?

For the upcoming 12 months, dividends amounting to 1.6 EUR are expected. This corresponds to a dividend yield of 1.37 %.

In which sector is DSM-Firmenich located?

DSM-Firmenich is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von DSM-Firmenich kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DSM-Firmenich from 5/16/2024 amounting to 1.568 EUR, you needed to have the stock in your portfolio before the ex-date on 5/9/2024.

When did DSM-Firmenich pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of DSM-Firmenich in the year 2023?

In the year 2023, DSM-Firmenich distributed 0 EUR as dividends.

In which currency does DSM-Firmenich pay out the dividend?

The dividends of DSM-Firmenich are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DSM-Firmenich

Our stock analysis for DSM-Firmenich Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DSM-Firmenich Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.